SLNO logo

SLNO
Soleno Therapeutics Inc

8,362
Mkt Cap
$2.7B
Volume
17.62M
52W High
$90.32
52W Low
$29.43
PE Ratio
234.41
SLNO Fundamentals
Price
$52.35
Prev Close
$52.25
Open
$52.29
50D MA
$38.16
Beta
0.89
Avg. Volume
1.66M
EPS (Annual)
$0.3909
P/B
6.07
Rev/Employee
$1.05M
$2,172.50
Loading...
Loading...
News
all
press releases
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky
Levi & Korsinsky, LLP alerts investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of a pending securities class action. Class Period: March 26, 2025 through November 4, 2025.Check if you can recover...
Business Wire·4h ago
News Placeholder
More News
News Placeholder
Top Mid Cap Stocks To Add to Your Watchlist - April 7th
ProShares UltraPro Short QQQ, Terns Pharmaceuticals, Direxion Daily TSLA Bull 2X Shares, Avis Budget Group, Applied Optoelectronics, Booking, and Soleno Therapeutics are the seven Mid Cap stocks to...
MarketBeat·5h ago
News Placeholder
SLNO SHAREHOLDER UPDATE: Soleno (SLNO) Facing Securities Class Action After DCCR Launch Setback, Share Drop-- Hagens Berman
SLNO SHAREHOLDER UPDATE: Soleno (SLNO) Facing Securities Class Action After DCCR Launch Setback, Share Drop-- Hagens Berman SLNO SHAREHOLDER UPDATE: Soleno (SLNO) Facing Securities Class Action After...
PR Newswire·8h ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading Volume - Here's What Happened
Soleno Therapeutics (NASDAQ:SLNO) Sees Large Volume Increase - What's Next...
MarketBeat·8h ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Receives "Hold" Rating from TD Cowen
TD Cowen reissued a "hold" rating and set a $53.00 target price (down from $85.00) on shares of Soleno Therapeutics in a research note on Tuesday...
MarketBeat·9h ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Earns Peer Perform Rating from Wolfe Research
Wolfe Research reaffirmed a "peer perform" rating on shares of Soleno Therapeutics in a research note on Tuesday...
MarketBeat·10h ago
News Placeholder
Company News for Apr 7, 2026
Companies in The News Are: SLNO,NBIX,MU,AAPL,SNDK
Zacks·10h ago
News Placeholder
SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm
SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm SLNO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Soleno Therapeutics, Inc. Securities Lawsuit -- The Gross Law Firm...
PR Newswire·11h ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Rating Lowered to "Hold" at Lifesci Capital
Lifesci Capital lowered shares of Soleno Therapeutics from a "strong-buy" rating to a "hold" rating in a research note on Monday...
MarketBeat·12h ago
News Placeholder
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement
Soleno Therapeutics (NASDAQ:SLNO), a rare-disease drug developer, closed Monday at $52.26, up 32.31%. The stock's move reflects Neurocrine Biosciences' (NASDAQ:NBIX) $53-per-share all-cash...
Nasdaq News: Markets·1d ago
<
1
2
...
>

Latest SLNO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.